Inventor · disambiguated record
Nico Bräuer
Also filed as: BRAEUER NICO · BRAUER NICO · BRÄUER NICO
13 granted patents·8 pending applications·27 citations·filing 2002–2023
87Inventor score
Top patents by PatentIndex Score
21 records- 0190US10202369B21,3-thiazol-2-yl substituted benzamidesBAYER AG·Filed 2017·Granted Feb 12, 2019·4 cites·26 claims
- 0289US10472354B21,3-thiazol-2-yl substituted benzamidesBAYER AG·Filed 2018·Granted Nov 12, 2019·3 cites·13 claims
- 0389US10174016B21,3-thiazol-2-yl substituted benzamidesBAYER AG·Filed 2015·Granted Jan 8, 2019·4 cites·34 claims
- 0488US10844016B2Aromatic sulfonamide derivativesBayer Pharma AG·Filed 2017·Granted Nov 24, 2020·7 cites·15 claims
- 0586US11142523B21,3-thiazol-2-yl substituted benzamidesBAYER AG·Filed 2019·Granted Oct 12, 2021·2 cites·16 claims
- 0681US10183937B21,3-thiazol-2-yl substituted benzamidesBAYER AG·Filed 2017·Granted Jan 22, 2019·4 cites·22 claims
- 0773US2023053411A11,3-thiazol-2-yl substituted benzamidesBAYER AG·Filed 2021·Application pending·0 cites
- 0871US9708311B2Benzimidazole derivatives as EP4 antagonistsBayer Pharma AG·Filed 2013·Granted Jul 18, 2017·2 cites·10 claims
- 0966US9655887B2Pharmaceutical composition and the use thereof, and application regime of said pharmaceutical composition for on-demand contraceptionBayer Pharma AG·Filed 2014·Granted May 23, 2017·1 cites·19 claims
- 1062US2024109850A1Covalent PPARG inverse-agonistsBAYER AG·Filed 2023·Application pending·0 cites
- 1157US11524938B2Aromatic sulfonamide derivativesBayer Pharma AG·Filed 2020·Granted Dec 13, 2022·0 cites·9 claims
- 1249US2025092014A1Compounds and methods of activating lipoprotein lipaseMETREA BIOSCIENCES INC·Filed 2022·Application pending·0 cites
- 1347US2010029599A1Indolylamides as modulators of the EP2 receptorBAYER SCHERING PHARMA AG·Filed 2009·Application pending·0 cites
- 1446US10730856B2Benzimidazole derivatives as EP4 ligandsBayer Pharma AG·Filed 2014·Granted Aug 4, 2020·0 cites·9 claims
- 1544US2008125435A11-(Het)aryl-3-[hetaryl-piperidin-4-yl]-thioureas as modulators of the EP2 receptorBRAUER NICO·Filed 2007·Application pending·0 cites
- 1641US9062041B22H-indazoles as EP2 receptor antagonistsBAYER IP GMBH·Filed 2012·Granted Jun 23, 2015·0 cites·9 claims
- 1741US2003171345A18Beta-substituted 11beta-aryl-estra-1,3,5,(10)-triene derivativesSCHERING AG·Filed 2002·Application pending·0 cites
- 1840US11319324B2Pyrazolo-pyrrolo-pyrimidine-dione derivatives as P2X3 inhibitorsBAYER AG·Filed 2018·Granted May 3, 2022·0 cites·11 claims
- 1939US2007197524A1Fluorenes and carbazoles as ligands of the EP2 receptorBRAUER NICO·Filed 2006·Application pending·0 cites
- 2038US10172814B2Substituted pyridyl-cycloalkyl-carboxylic acids, compositions containing them and medical uses thereofBayer Pharma AG·Filed 2015·Granted Jan 8, 2019·0 cites·21 claims
- 2133US2018338980A1Aromatic sulfonamide derivativesBayer Pharma AG·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →